☆ 4.3 Editorial Material

Living health technology assessments: how close to living reality?

BMJ EVIDENCE-BASED MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Article Economics

A Conceptual Framework for Life-Cycle Health Technology Assessment

Erin Kirwin et al.

Summary: The life-cycle health technology assessment (LC-HTA) framework addresses the challenges faced by standard HTA processes, such as decision uncertainty and lack of adaptability to new evidence. LC-HTA introduces changes in methods, such as risk-based pricing and research-oriented managed access, to minimize analytical time and improve decision certainty. The framework also extends value-of-information methods and includes contractually embedded decision rules to simplify reassessment and improve responsiveness to evolving evidence.

VALUE IN HEALTH (2022)

Add to Collection

Review Health Care Sciences & Services

Methodological challenges for living systematic reviews conducted during the COVID-19 pandemic: A concept paper

Claire Iannizzi et al.

Summary: A living systematic review (LSR) is an emerging review type that utilizes continual updating, making it suitable for addressing challenges brought about by the COVID-19 pandemic. Methodological considerations such as study design, interventions, comparators, changes in outcome measure, and search strategy are crucial when conducting LSRs in this context.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2022)

Add to Collection

Review Pharmacology & Pharmacy

A Review of Economic Models Submitted to NICE's Technology Appraisal Programme, for Treatments of T1DM & T2DM

Marie-Josee Daly et al.

Summary: This review examines the economic models used in diabetes treatments in the UK, specifically T1DM and T2DM, and assesses their compliance with the guidelines on computer modeling. The study finds that there are key issues with the current models' structure and methods, and recommends regular reassessment and adjustment.

FRONTIERS IN PHARMACOLOGY (2022)

Add to Collection

Review Medicine, General & Internal

Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making

Grammati Sarri et al.

Summary: This study developed a guidance using a mixed methods approach to direct researchers and healthcare decision-makers on when and how to combine evidence from non-randomised studies (NRS) and randomised controlled trials (RCTs) to enhance transparency and confidence. The framework consists of seven steps and offers recommendations on statistical approaches based on different healthcare decision-making scenarios.

BMJ EVIDENCE-BASED MEDICINE (2022)

Add to Collection

Editorial Material Multidisciplinary Sciences

Decision makers need 'living' evidence synthesis

Julian Elliott et al.

NATURE (2021)

Add to Collection

Article Health Care Sciences & Services

Machine learning reduced workload with minimal risk of missing studies: development and evaluation of a randomized controlled trial classifier for Cochrane Reviews

James Thomas et al.

Summary: The study developed a machine learning classifier to reduce study identification workload in Cochrane for producing systematic reviews. The calibrated classifier showed high recall in evaluation, with older records more likely to be missed compared to newer records.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2021)

Add to Collection

Editorial Material Health Care Sciences & Services

The 'Top 10' Challenges for Health Technology Assessment: INAHTA Viewpoint

Brian O'Rourke et al.

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2020)

Add to Collection

Article Health Care Sciences & Services

The new definition of health technology assessment: A milestone in international collaboration

Brian O'Rourke et al.

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2020)

Add to Collection

Article Economics

Managed Entry Agreements: Policy Analysis From the European Perspective

Monique Dabbous et al.

VALUE IN HEALTH (2020)

Add to Collection

Article Health Care Sciences & Services

Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU-actions for stakeholders

Karen M. Facey et al.

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2020)

Add to Collection

Article Economics

Uncertainty and Coverage With Evidence Development: Does Practice Meet Theory?

Xavier G. L. V. Pouwels et al.

VALUE IN HEALTH (2019)

Add to Collection

Article Medicine, General & Internal

Wasted research when systematic reviews fail to provide a complete and up-to-date evidence synthesis: the example of lung cancer

Perrine Crequit et al.

BMC MEDICINE (2016)

Add to Collection

Article Pharmacology & Pharmacy

Real World Data in Adaptive Biomedical Innovation: A Framework for Generating Evidence Fit for Decision-Making

S. Schneeweiss et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)

Add to Collection

Editorial Material Medicine, General & Internal

Living Systematic Reviews: An Emerging Opportunity to Narrow the Evidence-Practice Gap

Julian H. Elliott et al.

PLOS MEDICINE (2014)

Add to Collection

Review Medicine, General & Internal

Assessment of a method to detect signals for updating systematic reviews

Paul G. Shekelle et al.

SYSTEMATIC REVIEWS (2014)

Add to Collection

Article Health Care Sciences & Services

Model Parameter Estimation and Uncertainty Analysis: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6

Andrew H. Briggs et al.

MEDICAL DECISION MAKING (2012)

Add to Collection

Article Economics

Reducing Uncertainty in Value-Based Pricing Using Evidence Development Agreements The Case of Continuous Intraduodenal Infusion of Levodopa/Carbidopa (Duodopa®) in Sweden

Michael Willis et al.

APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2010)

Add to Collection

© Peeref 2019-2024. All rights reserved.